Multiomics – News and Features

New insights into fibrolamellar hepatocellular carcinoma could lead to new drugs and significantly improved health outcomes.

A new AI tool can accurately predict gene activity within any human cell, revealing the cell's inner mechanisms.

Salk researchers reveal PRIMER cells as central to plant immune defense, coordinating responses to pathogens in collaboration with neighboring "bystander" cells. Using advanced cell profiling, they uncovered the transcription factor GT-3a.

This article provides examples of where AI has been utilized to predict disease outbreaks and how AI models could help inform future strategies for controlling the spread of infectious diseases.

The SIMPL2 platform, developed by University of Toronto researchers, simplifies and improves protein interaction measurement, crucial for understanding disease mechanisms and developing drug therapies.

Parag Mallick, Stanford scientist and Nautilus co-founder, is looking to transform proteomics with a platform for proteome-wide analysis, advancing diagnostics and disease research.

Researchers have discovered a surprising link between a chronic gut infection caused by a common virus and the development of Alzheimer’s disease in a subset of people.

Hear from an early user of the neofleXTM MALDI-TOF instrument about how the technology adds new capabilities to MSI workflows.

This article examines some of the latest advances in biomarker discovery in the fields of cancer and neurodegenerative and infectious diseases and the technologies that are driving these discoveries.

City of Hope researchers discovered YTHDF2, a protein enabling blood cancers to evade CAR T cell therapy by hiding critical antigens. They developed CCI-38, a compound that suppresses YTHDF2, enhancing CAR T therapy's success.